Unaudited Forward-Looking Statements Regarding Business Outlook | ||||||
(In millions, except per share data) | ||||||
|
| ||||||
Business Outlook |
| Three Months Ending
| ||||
|
|
| GAAP
|
| Non-GAAP
|
| Non-GAAP
|
Gross margin |
| 60.0% |
| 0.0% |
| 60.0% |
|
|
|
|
|
|
|
|
Operating expenses |
| $114 |
| $24 |
| $90 |
|
|
|
|
|
|
|
|
Effective tax rate |
| 10.0% |
| 3.0% |
| 13.0% |
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share - low |
| $(0.11) |
| $0.53 |
| $0.42 |
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share - high |
| $(0.01) |
| $0.53 |
| $0.52 |
|
| ||||||
Silicon Laboratories Inc. | |||
Condensed Consolidated Balance Sheets | |||
(In thousands, except per share data) | |||
(Unaudited) | |||
|
| |||
|
| December 29,
|
| December 30, 2017 |
Assets |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents | $ 197,043 |
| $ 269,366 |
Short-term investments | 416,779 |
| 494,657 |
Accounts receivable, net | 73,194 |
| 71,367 |
Inventories | 74,972 |
| 73,132 |
Prepaid expenses and other current assets | 64,650 |
| 39,120 |
Total current assets | 826,638 |
| 947,642 |
Property and equipment, net | 139,049 |
| 127,682 |
Goodwill | 397,344 |
| 288,227 |
Other intangible assets, net | 170,832 |
| 83,144 |
Other assets, net | 90,491 |
| 88,387 |
Total assets | $1,624,354 |
| $1,535,082 |
|
|
|
|
|
Liabilities and Stockholders' Equity |
|
|
|
Current liabilities: |
|
|
|
Accounts payable | $ 41,171 |
| $ 38,851 |
| Deferred revenue and returns liability | 22,494 |
| -- |
| Deferred income on shipments to distributors | -- |
| 50,115 |
| Other current liabilities | 81,180 |
| 73,359 |
| Total current liabilities | 144,845 |
| 162,325 |
| Convertible debt | 354,771 |
| 341,879 |
| Other non-current liabilities | 57,448 |
| 77,862 |
| Total liabilities | 557,064 |
| 582,066 |
| Commitments and contingencies |
|
|
|
| Stockholders' equity: |
|
|
|
| Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued | -- |
| -- |
| Common stock – $0.0001 par value; 250,000 shares authorized; 43,088 and 42,707 shares issued and outstanding at December 29, 2018 and December 30, 2017, respectively | 4 |
| 4 |
| Additional paid-in capital | 107,517 |
| 102,862 |
| Retained earnings | 961,343 |
| 851,307 |
| Accumulated other comprehensive loss | (1,574) |
| (1,157) |
| Total stockholders' equity | 1,067,290 |
| 953,016 |
| Total liabilities and stockholders' equity | $1,624,354 |
| $1,535,082 |
